Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03360942 · ClinicalTrials.gov registry record · NA
Long Term Follow-up of Deep Brain Stimulation for Treatment-Resistant Depression
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03360942 is a NA study that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 5 participants.
The verdict
NCT03360942, a NA study, was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The long term follow up of a pilot study in which the investigators proposed to test whether high frequency stimulation of the subcallosal cingulate (SCC) is a safe and efficacious antidepressant treatment in five TRD patients, to compare the effects of left-sided vs. right-sided stimulation, and to investigate potential mechanisms of action of this intervention. Importantly, this study will be used to assess the need for and assist in planning a larger, more definitive trial of SCC Deep Brain Stimulation (DBS) for treatment-resistant depression (TRD).
Interventions
- DEVICE SCC DBS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2016-04-18 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03360942
The ClinicalTrials.gov registry entry for NCT03360942 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SCC DBS is the first listed.
NCT03360942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03360942 about?
NCT03360942 is a clinical study titled "Long Term Follow-up of Deep Brain Stimulation for Treatment-Resistant Depression". The long term follow up of a pilot study in which the investigators proposed to test whether high frequency stimulation of the subcallosal cingulate (SCC) is a safe and efficacious antidepressant treatment in five TRD patients, to compare the effects of left-sided vs. right-sided stimulation, and to...
What is the current status of trial NCT03360942?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2016-04-18. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT03360942?
The interventions under investigation include: SCC DBS (DEVICE).
Who is sponsoring clinical trial NCT03360942?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.